Amedeo's Top 20

Amedeo Smart

Independent Medical Education

06 April 2015

Multidisciplinary Journal Club

  1. Klein SL, Pekosz A.
    Sex-based Biology and the Rational Design of Influenza Vaccination Strategies.
    J Infect Dis 2014;209 :S114-9.

  1. Dawson R, Diacon AH, Everitt D, van Niekerk C, et al.
    Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible
    Lancet 2015.

  2. Rolfes M, Blanton L, Brammer L, Smith S, et al.
    Update: Influenza Activity - United States, September 28-December 6, 2014.
    MMWR Morb Mortal Wkly Rep 2014;63:1189-1194.

  3. Flannery B, Clippard J, Zimmerman RK, Nowalk MP, et al.
    Early estimates of seasonal influenza vaccine effectiveness - United States, january 2015.
    MMWR Morb Mortal Wkly Rep 2015;64:10-5.

  4. Liira J, Verbeek J, Ruotsalainen J.
    Pharmacological interventions for sleepiness and sleep disturbances caused by shift work.
    JAMA 2015;313:961-2.

  1. Nienaber CA, Clough RE.
    Management of acute aortic dissection.
    Lancet 2015;385:800-11.

  2. Dybkaer K, Bogsted M, Falgreen S, Bodker JS, et al.
    Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes With Prognosis.
    J Clin Oncol 2015.

  3. Joseph U, Linster M, Suzuki Y, Krauss S, et al.
    Adaptation of Pandemic H2N2 Influenza A Viruses in Humans.
    J Virol 2014.

  4. Pascual E, Mata CP, Gomez-Blanco J, Moreno N, et al.
    Structural basis for development of avian virus capsids to display influenza virus proteins for induction of protective immunity.
    J Virol 2014.

  5. Cooper DA, Banerjee S, Chakrabarti A, Garcia-Sastre A, et al.
    Ribonuclease L Targets Distinct Sites in Influenza A Virus RNAs.
    J Virol 2014.

  1. Cox A, Baker SF, Nogales A, Martinez-Sobrido L, et al.
    Development of a mouse-adapted, live-attenuated influenza virus that permits in vivo analysis of enhancements to the safety of LAIV.
    J Virol 2014.

  2. Gil A, Yassai MB, Naumov YN, Selin LK, et al.
    Narrowing of human influenza A virus specific T cell receptor alpha and beta repertoire with increasing age.
    J Virol 2015.

  3. Komori M, Blake A, Greenwood M, Lin YC, et al.
    CSF markers reveal intrathecal inflammation in progressive multiple sclerosis.
    Ann Neurol 2015.

  4. Cattoli G , Milani A, Temperton N, Zecchin B, et al.
    J Virol 2011.

  5. Kappos L, O'Connor P, Radue EW, Polman C, et al.
    Long-term effects of fingolimod in multiple sclerosis: The randomized FREEDOMS extension trial.
    Neurology 2015.

  1. Gorse GJ, Falsey AR, Ozol-Godfrey A, Landolfi V, et al.
    Safety and immunogenicity of a quadrivalent intradermal influenza vaccine in adults.
    Vaccine 2015.

  2. Curran E, Stock W.
    How I Treat: Acute Lymphoblastic Leukemia in Older Adolescents and Young Adults (AYAs).
    Blood 2015.

  3. Kim M , Yim JH, Kim SY, Kim HS, et al.
    In vitro inhibition of influenza A virus infection by marine microalga-derived sulfated polysaccharide p-KG03.
    Antiviral Res 2011.

  4. Zaidat OO, Fitzsimmons BF, Woodward BK, Wang Z, et al.
    Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial.
    JAMA 2015;313:1240-8.

  5. Smith TG , Ellison JA, Ma X, Kuzmina N, et al.
    An electrochemiluminescence assay for analysis of rabies virus glycoprotein content in rabies vaccines.
    Vaccine 2013.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016